Primary Pleural Squamous Cell Carcinoma, Highly Positive PD-L1, Shows Marked Response to Camrelizumab: A Case Report.

Wang, Yao; Gao, Ying; Chen, Hai-Ruo; Liu, Hong; Fu, Xi; Yan, Ran; You, Feng-Ming; Li, Zhuo-Hong

Wang, Yao; Gao, Ying; Chen, Hai-Ruo; Liu, Hong; Fu, Xi; Yan, Ran; You, Feng-Ming; Li, Zhuo-Hong.

Afiliación

Wang Y; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, China.
Gao Y; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, China.
Chen HR; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, China.
Liu H; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, China.
Fu X; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, China.
Yan R; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, China.
You FM; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, China.
Li ZH; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, China.

Clin Med Insights Oncol ; 15: 11795549211028571, 2021.

Article en En | MEDLINE | ID: mdl-34290540

Palabras clave

Primary pleural squamous; camrelizumab; case report; therapeutic

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Med Insights Oncol Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google